Repurposing of Bromocriptine for Cancer Therapy - Wikidata - wikimedia - TriplyDB

Repurposing of Bromocriptine for Cancer Therapy

Repurposing of Bromocriptine for Cancer Therapy

http://www.wikidata.org/entity/Q57817601

about

Repurposing of Bromocriptine for Cancer Therapy

http://www.wikidata.org/entity/Q57817601

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Repurposing of Bromocriptine for Cancer Therapy

@en

Repurposing of Bromocriptine for Cancer Therapy

@nl

type

label

Repurposing of Bromocriptine for Cancer Therapy

@en

Repurposing of Bromocriptine for Cancer Therapy

@nl

prefLabel

Repurposing of Bromocriptine for Cancer Therapy

@en

Repurposing of Bromocriptine for Cancer Therapy

@nl

P1433

Q57817601-F0A642C6-8494-4BD9-80C7-F0F0B97D43BF

P1476

Q57817601-3AEC3518-DAB6-4BDC-99E1-7BB22BD7F14A

P2093

Q57817601-2FC902CD-56F0-4C7D-901C-6D6657346DC5

Q57817601-5E25BEB4-8172-4EB0-8D98-E8573C3E46B5

Q57817601-856AF701-437B-482F-9927-204989A71221

Q57817601-9BA0862E-AD0A-406B-955E-0ACF9E36EC2A

P2860

Q57817601-033377F7-6E27-4FF9-89BB-8D1B31A6D252

Q57817601-0394FF28-AF71-4BD7-BA68-F69308BE004F

Q57817601-04B25C5F-46BC-44EB-A86E-D6FACF3948B6

Q57817601-06E2A452-7430-4794-B75E-507FDA194AE6

Q57817601-105212DF-D58A-44FF-A69A-C18BD6C90FF6

Q57817601-18A1D71A-7CA4-4765-903D-B8F112659ADF

Q57817601-1EA92047-E2E5-4640-9E5F-A166B22A1EE7

Q57817601-21F12369-EB02-4146-831A-0E55C73DF974

Q57817601-222EBAF9-AA49-433C-91B9-DE148C669D90

Q57817601-22CF9DBA-9661-4222-AA02-005A9ED1C933

P304

Q57817601-CFA700A8-D5C1-4B4A-BF73-227A1EBFAC6B

P31

Q57817601-87AB61CB-0C2B-421C-9E8A-74E875B022FC

P356

Q57817601-84EF63F9-2AF5-4602-A6B2-DA37B1FEEB0B

P407

Q57817601-54F6C65D-8693-45A5-AEE4-2C52F65EC2D9

P478

Q57817601-086FE348-B9D1-49B3-AD7E-ED22654A12CE

P577

Q57817601-6C43FD8C-2402-42B7-9AA5-3FEE1B68B2C8

P698

Q57817601-6B592248-93CF-4D46-9D71-573E56338749

P921

Q57817601-68FC738B-03B4-4D3A-91C0-3FF9207041FA

P932

Q57817601-43D87E7C-CB63-4E64-997C-351549E5EEB2

P356

FPHAR.2018.01030

P1433

Frontiers in Pharmacology

P1476

Repurposing of Bromocriptine for Cancer Therapy

@en

P2093

Ean-Jeong Seo

http://www.w3.org/2001/XMLSchema#string

Henry Johannes Greten

http://www.w3.org/2001/XMLSchema#string

Thomas Efferth

http://www.w3.org/2001/XMLSchema#string

Yoshikazu Sugimoto

http://www.w3.org/2001/XMLSchema#string

P2860

A multidrug resistance transporter from human MCF-7 breast cancer cells

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes

A review of the receptor-binding and pharmacokinetic properties of dopamine agonists

Factors determining sensitivity and resistance of tumor cells to arsenic trioxide

Shared principles in NF-kappaB signaling

Drug repositioning: identifying and developing new uses for existing drugs

Biochemistry of multidrug resistance mediated by the multidrug transporter

A gene expression database for the molecular pharmacology of cancer

Prolactin-induced neuroprotection against glutamate excitotoxicity is mediated by the reduction of [Ca2+]i overload and NF-κB activation.

The role of NF-kappaB/IkappaB proteins in cancer: implications for novel treatment strategies.

P304

1030

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.01030

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30349477

http://www.w3.org/2001/XMLSchema#string

P921

P932

6187981

http://www.w3.org/2001/XMLSchema#string